Does dapagliflozin regress left ventricular hypertrophy in patients with type 2 diabetes? A prospective, double-blind, randomised, placebo-controlled study (Q41507487)
Jump to navigation
Jump to search
scientific article published on 23 August 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Does dapagliflozin regress left ventricular hypertrophy in patients with type 2 diabetes? A prospective, double-blind, randomised, placebo-controlled study |
scientific article published on 23 August 2017 |
Statements
1 reference
Does dapagliflozin regress left ventricular hypertrophy in patients with type 2 diabetes? A prospective, double-blind, randomised, placebo-controlled study (English)
1 reference
1 reference
Alexander J M Brown
1 reference
23 August 2017
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference